- Home
- CODX vs MNDO Comparison
CODX vs MNDO Comparison
Compare CODX & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- MNDO
- Stock Information
- Founded
- CODX 2013
- MNDO 1995
- Country
- CODX United States
- MNDO Israel
- Employees
- CODX N/A
- MNDO N/A
- Industry
- CODX Medical/Dental Instruments
- MNDO EDP Services
- Sector
- CODX Health Care
- MNDO Technology
- Exchange
- CODX Nasdaq
- MNDO Nasdaq
- Market Cap
- CODX 39.3M
- MNDO 39.7M
- IPO Year
- CODX 2017
- MNDO 2000
- Fundamental
- Price
- CODX $1.06
- MNDO $1.96
- Analyst Decision
- CODX Hold
- MNDO
- Analyst Count
- CODX 1
- MNDO 0
- Target Price
- CODX $1.50
- MNDO N/A
- AVG Volume (30 Days)
- CODX 90.9K
- MNDO 24.5K
- Earning Date
- CODX 11-07-2024
- MNDO 11-05-2024
- Dividend Yield
- CODX N/A
- MNDO 12.28%
- EPS Growth
- CODX N/A
- MNDO N/A
- EPS
- CODX N/A
- MNDO 0.23
- Revenue
- CODX $7,321,012.00
- MNDO $21,856,000.00
- Revenue This Year
- CODX N/A
- MNDO N/A
- Revenue Next Year
- CODX N/A
- MNDO N/A
- P/E Ratio
- CODX N/A
- MNDO $8.50
- Revenue Growth
- CODX 57.16
- MNDO 2.27
- 52 Week Low
- CODX $1.00
- MNDO $1.70
- 52 Week High
- CODX $2.23
- MNDO $2.28
- Technical
- Relative Strength Index (RSI)
- CODX 34.55
- MNDO 49.10
- Support Level
- CODX $1.02
- MNDO $1.94
- Resistance Level
- CODX $1.09
- MNDO $2.00
- Average True Range (ATR)
- CODX 0.05
- MNDO 0.03
- MACD
- CODX -0.01
- MNDO -0.00
- Stochastic Oscillator
- CODX 21.74
- MNDO 58.20
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets and implements real-time and off-line convergent billing and customer care software solutions. The company derives revenue from sale of software products and services in two operating segments namely Billing and Related Services, which derives key revenue and Messaging. The Company has three product lines: Product line A- billing and customer care solutions for service providers; Product line B - call accounting and call management solutions for enterprises; and Product line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in The Americas, Europe, Asia Pacific and Africa and Israel. It earns maximum revenue from Europe.